<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38424104</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>29</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>IFN-&#x3b3; decreases PD-1 in T lymphocytes from convalescent COVID-19 patients via the AKT/GSK3&#x3b2; signaling pathway.</ArticleTitle><Pagination><StartPage>5038</StartPage><MedlinePgn>5038</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5038</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-55191-6</ELocationID><Abstract><AbstractText>Post-COVID-19 syndrome may be associated with the abnormal immune status. Compared with the unexposed age-matched elder group, PD-1 in the CD8<sup>+</sup> T cells from recovered COVID-19 patients was significantly lower. IFN-&#x3b3; in the plasma of COVID-19 convalescent patients was increased, which inhibited PD-1 expression in CD8<sup>+</sup> T cells from COVID-19 convalescent patients. scRNA-seq bioinformatics analysis revealed that AKT/GSK3&#x3b2; may regulate the INF-&#x3b3;/PD-1 axis in CD8<sup>+</sup> T cells from COVID-19 convalescent patients. In parallel, an IFN-&#x3b3; neutralizing antibody reduced AKT and increased GSK3&#x3b2; in PBMCs. An AKT agonist (SC79) significantly decreased p-GSK3&#x3b2;. Moreover, AKT decreased PD-1 on CD8<sup>+</sup> T cells, and GSK3&#x3b2; increased PD-1 on CD8<sup>+</sup> T cells according to flow cytometry analysis. Collectively, we demonstrated that recovered COVID-19 patients may develop long COVID. Increased IFN-&#x3b3; in the plasma of recovered Wuhan COVID-19 patients contributed to PD-1 downregulation on CD8<sup>+</sup> T cells by regulating the AKT/GSK3&#x3b2; signaling pathway.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Song</LastName><ForeName>Meijuan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Xiangqun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The Xuzhou Municipal Hospital Affiliated to Xuzhou Medical University, Xuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Shen</LastName><ForeName>Weiyu</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhengxia</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jingjing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Jingxian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yanan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bian</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Mingshun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Jiangsu Province Engineering Research Center of Antibody Drug, NHC Key Laboratory of Antibody Technique, Department of Immunology, Nanjing Medical University, Nanjing, China. mingshunzhang@njmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Xishan People's Hospital of Wuxi City, Wuxi, China. sunweiwx@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Mao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China. hm6114@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Ningfei</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China. jiningfei@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>BE2020616</GrantID><Agency>Jiangsu Provincial Key Research and Development Program</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D000071679">Glycogen Synthase Kinase 3 beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>82115-62-6</RegistryNumber><NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D061026">Programmed Cell Death 1 Receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C105992">PDCD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C573415">IFNG protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="Y">CD8-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071679" MajorTopicYN="N">Glycogen Synthase Kinase 3 beta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061026" MajorTopicYN="N">Programmed Cell Death 1 Receptor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD8+ T cells</Keyword><Keyword MajorTopicYN="N">Convalescent patients</Keyword><Keyword MajorTopicYN="N">Coronavirus disease 2019</Keyword><Keyword MajorTopicYN="N">IFN-&#x3b3;</Keyword><Keyword MajorTopicYN="N">PD-1</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>1</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>29</Day><Hour>23</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38424104</ArticleId><ArticleId IdType="pmc">PMC10904811</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-55191-6</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-55191-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid. Soc. Sci. Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Zhao J, Perlman S. T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice. J. Virol. 2010;84:9318&#x2013;9325. doi: 10.1128/JVI.01049-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01049-10</ArticleId><ArticleId IdType="pmc">PMC2937604</ArticleId><ArticleId IdType="pubmed">20610717</ArticleId></ArticleIdList></Reference><Reference><Citation>Elahi S, et al. Protective HIV-specific CD8+ T cells evade Treg cell suppression. Nat Med. 2011;17:989&#x2013;995. doi: 10.1038/nm.2422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2422</ArticleId><ArticleId IdType="pmc">PMC3324980</ArticleId><ArticleId IdType="pubmed">21765403</ArticleId></ArticleIdList></Reference><Reference><Citation>Migueles SA, et al. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity. 2008;29:1009&#x2013;1021. doi: 10.1016/j.immuni.2008.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2008.10.010</ArticleId><ArticleId IdType="pmc">PMC2622434</ArticleId><ArticleId IdType="pubmed">19062316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed R, Salmi A, Butler LD, Chiller JM, Oldstone MB. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 1984;160:521&#x2013;540. doi: 10.1084/jem.160.2.521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.160.2.521</ArticleId><ArticleId IdType="pmc">PMC2187458</ArticleId><ArticleId IdType="pubmed">6332167</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordenfelt E, Andr&#xe9;n-Sandberg M. Dane particle-associated DNA polymerase and e antigen: Relation to chronic hepatitis among carriers of hepatitis B surface antigen. J. Infect. Dis. 1976;134:85&#x2013;89. doi: 10.1093/infdis/134.1.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/134.1.85</ArticleId><ArticleId IdType="pubmed">939924</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu HY, et al. Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus. Hepatology. 1992;15:770&#x2013;776. doi: 10.1002/hep.1840150505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.1840150505</ArticleId><ArticleId IdType="pubmed">1568717</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg W. Mechanisms of immune escape in viral hepatitis. Gut. 1999;44:759&#x2013;764. doi: 10.1136/gut.44.5.759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.44.5.759</ArticleId><ArticleId IdType="pmc">PMC1727502</ArticleId><ArticleId IdType="pubmed">10205220</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertoni R, et al. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Investig. 1997;100:503&#x2013;513. doi: 10.1172/JCI119559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI119559</ArticleId><ArticleId IdType="pmc">PMC508216</ArticleId><ArticleId IdType="pubmed">9239396</ArticleId></ArticleIdList></Reference><Reference><Citation>Taeschler P, et al. T-cell recovery and evidence of persistent immune activation 12 months after severe COVID-19. Allergy. 2022;77:2468&#x2013;2481. doi: 10.1111/all.15372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15372</ArticleId><ArticleId IdType="pmc">PMC9347640</ArticleId><ArticleId IdType="pubmed">35567391</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman GJ, Wherry EJ, Ahmed R, Sharpe AH. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J. Exp. Med. 2006;203:2223&#x2013;2227. doi: 10.1084/jem.20061800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20061800</ArticleId><ArticleId IdType="pmc">PMC2118103</ArticleId><ArticleId IdType="pubmed">17000870</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahan SM, Wherry EJ, Zajac AJ. T cell exhaustion during persistent viral infections. Virology. 2015;479&#x2013;480:180&#x2013;193. doi: 10.1016/j.virol.2014.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2014.12.033</ArticleId><ArticleId IdType="pmc">PMC4424083</ArticleId><ArticleId IdType="pubmed">25620767</ArticleId></ArticleIdList></Reference><Reference><Citation>Wherry EJ, et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity. 2007;27:670&#x2013;684. doi: 10.1016/j.immuni.2007.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2007.09.006</ArticleId><ArticleId IdType="pubmed">17950003</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin H, Wherry EJ. CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol. 2007;19:408&#x2013;415. doi: 10.1016/j.coi.2007.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2007.06.004</ArticleId><ArticleId IdType="pubmed">17656078</ArticleId></ArticleIdList></Reference><Reference><Citation>Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 2008;26:677&#x2013;704. doi: 10.1146/annurev.immunol.26.021607.090331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.26.021607.090331</ArticleId><ArticleId IdType="pmc">PMC10637733</ArticleId><ArticleId IdType="pubmed">18173375</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nrich G, Raftery MJ. The PD-1/PD-L1 axis and virus infections: A delicate balance. Front. Cell. Infect. Microbiol. 2019;9:207. doi: 10.3389/fcimb.2019.00207.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00207</ArticleId><ArticleId IdType="pmc">PMC6584848</ArticleId><ArticleId IdType="pubmed">31263684</ArticleId></ArticleIdList></Reference><Reference><Citation>Puronen CE, Ford ES, Uldrick TS. Immunotherapy in people with HIV and cancer. Front. Immunol. 2019;10:2060. doi: 10.3389/fimmu.2019.02060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02060</ArticleId><ArticleId IdType="pmc">PMC6722204</ArticleId><ArticleId IdType="pubmed">31555284</ArticleId></ArticleIdList></Reference><Reference><Citation>Day CL, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443:350&#x2013;354. doi: 10.1038/nature05115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05115</ArticleId><ArticleId IdType="pubmed">16921384</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion. Science. 2011;331:1565&#x2013;1570. doi: 10.1126/science.1203486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1203486</ArticleId><ArticleId IdType="pubmed">21436444</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19) Front. Immunol. 2020;11:827. doi: 10.3389/fimmu.2020.00827.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00827</ArticleId><ArticleId IdType="pmc">PMC7205903</ArticleId><ArticleId IdType="pubmed">32425950</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellesi S, et al. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients. Br. J. Haematol. 2020;191:207&#x2013;211. doi: 10.1111/bjh.17034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.17034</ArticleId><ArticleId IdType="pmc">PMC7405050</ArticleId><ArticleId IdType="pubmed">32679621</ArticleId></ArticleIdList></Reference><Reference><Citation>Rha MS, et al. PD-1-expressing SARS-CoV-2-Specific CD8(+) T cells are not exhausted, but functional in patients with COVID-19. Immunity. 2021;54:44&#x2013;52.e43. doi: 10.1016/j.immuni.2020.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.12.002</ArticleId><ArticleId IdType="pmc">PMC7834198</ArticleId><ArticleId IdType="pubmed">33338412</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokosuka T, et al. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J. Exp. Med. 2012;209:1201&#x2013;1217. doi: 10.1084/jem.20112741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20112741</ArticleId><ArticleId IdType="pmc">PMC3371732</ArticleId><ArticleId IdType="pubmed">22641383</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi MJ, et al. Suicide associated with COVID-19 infection: An immunological point of view. Eur. Rev. Med. Pharmacol. Sci. 2021;25:6397&#x2013;6407.</Citation><ArticleIdList><ArticleId IdType="pubmed">34730221</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, et al. Different profiles of antibodies and cytokines were found between severe and moderate COVID-19 patients. Front. Immunol. 2021;12:723585. doi: 10.3389/fimmu.2021.723585.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.723585</ArticleId><ArticleId IdType="pmc">PMC8417126</ArticleId><ArticleId IdType="pubmed">34489974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben Nasr M, et al. Indirect and direct effects of SARS-CoV-2 on human pancreatic islets. Diabetes. 2022;71:1579&#x2013;1590. doi: 10.2337/db21-0926.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db21-0926</ArticleId><ArticleId IdType="pmc">PMC9490452</ArticleId><ArticleId IdType="pubmed">35499468</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: An overview of signals, mechanisms and functions. J. Leukoc. Biol. 2004;75:163&#x2013;189. doi: 10.1189/jlb.0603252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0603252</ArticleId><ArticleId IdType="pubmed">14525967</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding G, et al. IFN-&#x3b3; down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer. BMC Cancer. 2019;19:1053. doi: 10.1186/s12885-019-6145-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-019-6145-8</ArticleId><ArticleId IdType="pmc">PMC6836337</ArticleId><ArticleId IdType="pubmed">31694582</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, et al. PD-1 deficiency promotes TFH cells expansion in ITV-immunized mice by upregulating cytokines secretion. Parasit. Vectors. 2018;11:397. doi: 10.1186/s13071-018-2984-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13071-018-2984-4</ArticleId><ArticleId IdType="pmc">PMC6035468</ArticleId><ArticleId IdType="pubmed">29980219</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine T, et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell. 2020;183:158&#x2013;168.e114. doi: 10.1016/j.cell.2020.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.017</ArticleId><ArticleId IdType="pmc">PMC7427556</ArticleId><ArticleId IdType="pubmed">32979941</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajpai M, et al. Efficacy of convalescent plasma therapy in the patient with COVID-19: A randomised control trial (COPLA-II trial) BMJ Open. 2022;12:e055189. doi: 10.1136/bmjopen-2021-055189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-055189</ArticleId><ArticleId IdType="pmc">PMC8987237</ArticleId><ArticleId IdType="pubmed">35387813</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinselmeyer BH, et al. PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis. J. Exp. Med. 2013;210:757&#x2013;774. doi: 10.1084/jem.20121416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20121416</ArticleId><ArticleId IdType="pmc">PMC3620347</ArticleId><ArticleId IdType="pubmed">23530125</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy WJ, Longo DL. A possible role for anti-idiotype antibodies in SARS-CoV-2 infection and vaccination. N. Engl. J. Med. 2022;386:394&#x2013;396. doi: 10.1056/NEJMcibr2113694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2113694</ArticleId><ArticleId IdType="pubmed">34818473</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X, et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell. 2021;184:1895&#x2013;1913.e1819. doi: 10.1016/j.cell.2021.01.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.053</ArticleId><ArticleId IdType="pmc">PMC7857060</ArticleId><ArticleId IdType="pubmed">33657410</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalia V, et al. Metabolic regulation by PD-1 signaling promotes long-lived quiescent CD8 T cell memory in mice. Sci. Transl. Med. 2021;13:eaba6006. doi: 10.1126/scitranslmed.aba6006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aba6006</ArticleId><ArticleId IdType="pmc">PMC8896520</ArticleId><ArticleId IdType="pubmed">34644150</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai X, et al. Improvement of PD-1 blockade efficacy and elimination of immune-related gastrointestinal adverse effect by mTOR inhibitor. Front. Immunol. 2021;12:793831. doi: 10.3389/fimmu.2021.793831.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.793831</ArticleId><ArticleId IdType="pmc">PMC8721049</ArticleId><ArticleId IdType="pubmed">34987517</ArticleId></ArticleIdList></Reference><Reference><Citation>Swain SL, McKinstry KK, Strutt TM. Expanding roles for CD4+ T cells in immunity to viruses. Nat. Rev. Immunol. 2012;12:136&#x2013;148. doi: 10.1038/nri3152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3152</ArticleId><ArticleId IdType="pmc">PMC3764486</ArticleId><ArticleId IdType="pubmed">22266691</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, et al. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. J. Virol. 2010;84:1289&#x2013;1301. doi: 10.1128/JVI.01281-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01281-09</ArticleId><ArticleId IdType="pmc">PMC2812346</ArticleId><ArticleId IdType="pubmed">19906920</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw AC, Goldstein DR, Montgomery RR. Age-dependent dysregulation of innate immunity. Nat. Rev. Immunol. 2013;13:875&#x2013;887. doi: 10.1038/nri3547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3547</ArticleId><ArticleId IdType="pmc">PMC4096436</ArticleId><ArticleId IdType="pubmed">24157572</ArticleId></ArticleIdList></Reference><Reference><Citation>Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science. 2020;368:860&#x2013;868. doi: 10.1126/science.abb5793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb5793</ArticleId><ArticleId IdType="pmc">PMC7164482</ArticleId><ArticleId IdType="pubmed">32291278</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, et al. Single-cell sequencing of peripheral mononuclear cells reveals distinct immune response landscapes of COVID-19 and influenza patients. Immunity. 2020;53:685&#x2013;696.e683. doi: 10.1016/j.immuni.2020.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.07.009</ArticleId><ArticleId IdType="pmc">PMC7368915</ArticleId><ArticleId IdType="pubmed">32783921</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T, Su TT, Mudianto T, Wang J. Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies. J. Exp. Med. 2020;217:e20200674. doi: 10.1084/jem.20200674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20200674</ArticleId><ArticleId IdType="pmc">PMC7481961</ArticleId><ArticleId IdType="pubmed">32910820</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis. 2020;71:762&#x2013;768. doi: 10.1093/cid/ciaa248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa248</ArticleId><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, et al. Longitudinal characteristics of T cell responses in asymptomatic SARS-CoV-2 infection. Virol. Sin. 2020;35:838&#x2013;841. doi: 10.1007/s12250-020-00277-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-020-00277-4</ArticleId><ArticleId IdType="pmc">PMC7441833</ArticleId><ArticleId IdType="pubmed">32822061</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni L, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020;52:971&#x2013;977.e973. doi: 10.1016/j.immuni.2020.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.04.023</ArticleId><ArticleId IdType="pmc">PMC7196424</ArticleId><ArticleId IdType="pubmed">32413330</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B, et al. Alterations in phenotypes and responses of T cells within 6 months of recovery from COVID-19: A cohort study. Virol. Sin. 2021;36:859&#x2013;868. doi: 10.1007/s12250-021-00348-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-021-00348-0</ArticleId><ArticleId IdType="pmc">PMC7871951</ArticleId><ArticleId IdType="pubmed">33560482</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, et al. PD-1 blockade restores the proliferation of peripheral blood lymphocyte and inhibits lymphocyte apoptosis in a BALB/c mouse model of CP BVDV acute infection. Front. Immunol. 2021;12:727254. doi: 10.3389/fimmu.2021.727254.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.727254</ArticleId><ArticleId IdType="pmc">PMC8450576</ArticleId><ArticleId IdType="pubmed">34552590</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen CX, et al. Narrative review of emerging roles for AKT-mTOR signaling in cancer radioimmunotherapy. Ann. Transl. Med. 2021;9:1596. doi: 10.21037/atm-21-4544.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-21-4544</ArticleId><ArticleId IdType="pmc">PMC8576660</ArticleId><ArticleId IdType="pubmed">34790802</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta S, Katz SC, Sengupta S, Sampath P. Glycogen synthase kinase 3 inhibition lowers PD-1 expression, promotes long-term survival and memory generation in antigen-specific CAR-T cells. Cancer Lett. 2018;433:131&#x2013;139. doi: 10.1016/j.canlet.2018.06.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2018.06.035</ArticleId><ArticleId IdType="pubmed">29959057</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullard A. FDA approves first-in-class AKT inhibitor. Nat. Rev. Drug Discov. 2024;23:9. doi: 10.1038/d41573-023-00202-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41573-023-00202-w</ArticleId><ArticleId IdType="pubmed">38049466</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann AD, et al. Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients. Clin. Immunol. 2023;252:109634. doi: 10.1016/j.clim.2023.109634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2023.109634</ArticleId><ArticleId IdType="pmc">PMC10162478</ArticleId><ArticleId IdType="pubmed">37150240</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroemer M, et al. The quality of anti-SARS-CoV-2 T cell responses predicts the neutralizing antibody titer in convalescent plasma donors. Front. Public Health. 2022;10:816848. doi: 10.3389/fpubh.2022.816848.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.816848</ArticleId><ArticleId IdType="pmc">PMC8965758</ArticleId><ArticleId IdType="pubmed">35372242</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing Y, et al. SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism. Signal Transduct. Target. Ther. 2021;6:345. doi: 10.1038/s41392-021-00749-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00749-3</ArticleId><ArticleId IdType="pmc">PMC8456405</ArticleId><ArticleId IdType="pubmed">34552055</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>